Disc Medicine Highlights Clinical And Preclinical Data From BEACON And AURORA Trials Of Bitopertin And Phase 1 DISC-3405 Trial At ASH 2024, Showcasing Potential For Existing And New Indications While Advancing Pipeline Of Hematologic Disease Therapies
Disc Medicine Highlights Clinical And Preclinical Data From BEACON And AURORA Trials Of Bitopertin And Phase 1 DISC-3405 Trial At ASH 2024, Showcasing Potential For Existing And New Indications While Advancing Pipeline Of Hematologic Disease Therapies
Disc Medicine在2024年ASH大會上重點展示了Bitopertin的BEACON和AURORA試驗的臨床及前臨床數據，以及1期DISC-3405試驗，展示了現有和新適應症的潛力，同時推進了血液疾病療法的研發管線。
Disc Medicine Highlights Clinical And Preclinical Data From BEACON And AURORA Trials Of Bitopertin And Phase 1 DISC-3405 Trial At ASH 2024, Showcasing Potential For Existing And New Indications While Advancing Pipeline Of Hematologic Disease Therapies
Disc Medicine在2024年ASH大會上重點展示了Bitopertin的BEACON和AURORA試驗的臨床及前臨床數據，以及1期DISC-3405試驗，展示了現有和新適應症的潛力，同時推進了血液疾病療法的研發管線。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間